Yatharth Hospital & Trauma Care Services Ltd IPO Timeline

Yatharth Hospital & Trauma Care Services Ltd IPO opens on 26-Jul-2023, and closes on 28-Jul-2023. The Yatharth Hospital & Trauma Care Services Ltd IPO bid date is from 26-Jul-2023 to 28-Jul-2023. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.

Event Date
Yatharth Hospital & Trauma Care Services Ltd IPO Opening Date 26-Jul-2023
Yatharth Hospital & Trauma Care Services Ltd IPO Closing Date 28-Jul-2023
Basis of Allotment 02-Aug-2023
Initiation of Refunds 03-Aug-2023
Credit of Shares to Demat 04-Aug-2023
Yatharth Hospital & Trauma Care Services Ltd IPO Listing Date 07-Aug-2023

Yatharth Hospital & Trauma Care Services Ltd IPO Lot Size

Yatharth Hospital & Trauma Care Services Ltd IPO lot size is 50 shares. A retail-individual investor can apply for up to 13 lots (650 shares or 195000).

Application Lots Shares Amount
Minimum 1 50 ₹15000
Maximum 13 650 ₹195000

Yatharth Hospital & Trauma Care Services Ltd IPO Details

Yatharth Hospital & Trauma Care Services Ltd IPO Date 26-Jul-2023 to 28-Jul-2023
Yatharth Hospital & Trauma Care Services Ltd IPO Face Value Shares of ₹10 per share
Yatharth Hospital & Trauma Care Services Ltd IPO Price ₹285 to ₹300 per share
Yatharth Hospital & Trauma Care Services Ltd IPO Lot Size 50
Issue Size Shares of ₹10 (aggregating up to ₹686.55 Cr)
Fresh Issue Shares of ₹10 (aggregating up to ₹490 Cr)
Offer for Sale Shares of ₹10 (aggregating up to ₹186.72 Cr)
Issue Type Book Built Portion
Listing At BSE, NSE
QIB Shares Offered Not more than 4645486
Retail Shares Offered Not less than 8310636
NII (HNI) Shares Offered Not less than 3561701
Company Promoters Ajay Kumar Thyagi, Kapil Kumar.

Objects of the Issue

The company proposes to utilise the Net Proceeds from the Fresh Issue towards funding the following objects:

  • 1 Repayment/prepayment, in full or part, of certain borrowings availed by the company
  • 2 Repayment/prepayment, in full or part of certain borrowings availed by the subsidiary, namely AKS & Ramraja
  • 3 Funding capital expenditure expensess of the company for two hospitals namely Noida Hospital & Greater Noida Hospital
  • 4 Funding capital expenditure expensess of the subsidiary AKS & Ramraja for respective hospital operated by them
  • 5 Funding inorganic growth initiatives through acquisition and other strategic initiatives
  • 6 General corporate purposes

Company Financials

Yatharth Hospital & Trauma Care Services Ltd Financial Information (Restated)

Period Ended Total Assets Total Revenue Profit After Tax
03-2023 326.23 373.11 64.17
03-2022 285.87 299.86 42.09
03-2021 207.75 165.24 15.50
Amount in ₹ Crore
  • Among the leading super-specialty hospital in Delhi NCR with diverse specialty and payer mix.
  • Advanced and high-end medical equipment and technology.
  • Ability to attract quality doctors, nurses, paramedical, and other staff.
  • Experienced and qualified professional management team with strong execution track record.
  • Track record of stable operating and financial performance and growth.
  • The Hospital is highly dependent on doctors, nurses and other healthcare professionals and its business and financial performance will be impacted significantly if the Hospital unable to attract, retain or train such professionals.
  • As a healthcare provider, the ongoing COVID-19 pandemic, stringent restrictions to slow down the Hospital spread and its resulting impact is uncertain, may be significant and continue to have an adverse effect on its business, operations and the Hospital future financial performance.
  • The Hospital operations are concentrated in the Delhi NCR region. Its also significantly dependent on certain specialties for a majority of the Hospital revenues. Any impact on the revenues from these hospitals or earnings from its top specialties could materially affect the Hospital business, financial condition, results of operations and cash flows.
  • The Hospital business depends on the strength of its brand and reputation. Failure to maintain and enhance its brand and reputation, and any negative publicity and allegations in the media against it, may materially and adversely affect the level of market recognition of, and trust in, the Hospital services, which could result in a material adverse impact on its business, financial condition, results of operations and prospects.
  • Because of the risks typically associated with the operation of medical care facilities, patients may contract serious communicable infections or diseases at its facilities.
  • The Hospital is subject to various operational, reputational, medical and legal claims, regulatory actions or other liabilities arising from the provision of healthcare services and may be subject to liabilities arising from claims of malpractice and medical negligence which could materially and adversely affect its reputation and prospects.
  • The Hospital may not be successful in expanding its operations to other parts of India which could have an adverse effect on the Hospital business, financial condition, results of operations and cash flows. If the Hospital is unable to successfully identify and integrate acquisitions, its growth strategy and prospects may be adversely affected.
  • If the Hospital is unable to increase the hospital occupancy rates, Its may not be able to generate adequate returns on the Hospital capital expenditures, which could materially adversely affect its operating efficiencies and th Hospital profitability.
  • The provision of healthcare services has high costs such as manpower cost, infrastructure maintenance and repair cost, high medical equipment cost and any failure to pass on such costs to the patients may have a material adverse impact on its business, financial condition, results of operations and prospects.
  • The Hospital arrangements with certain of its doctors are on a consultancy basis. If such doctors discontinue their association with it or are unable to provide their services at the hospitals for any reason or if the Hospital is unable to attract or retain such consultants, and other healthcare professionals, its business, results of operations and cash flows may be materially and adversely affected.
  • The Hospital relies on third party suppliers and manufacturers for its supplies and equipment. Failure of such third parties to meet their obligations could adversely affect the Hospital business, results of operations and cash flows.
  • The Hospital face competition from other hospitals, pharmacies and other healthcare services providers. Any adverse effects on its competitive position could result in a decline in its business, revenues, profitability and market share.
  • The Hospital is required to adapt to rapidly evolving technological advancements related to its medical equipment and technology, failure of which could adversely affect its business prospects and financial performance.
  • The Hospital operate in a highly regulated industry, and compliance with applicable safety, health, environmental and other governmental regulations and any violations of existing regulations may adversely affect its business, financial condition, results of operations and cash flows.
  • Regulatory reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing and other matters could adversely affect the Hospital business, results of operations and cash flows.
  • The Hospital may not be able to successfully integrate its acquisitions or investments, which may negatively affect their performance and respective contributions to the Hospital results of operations.
  • Failure to obtain or renew approvals, licenses, registrations and permits to operate the Hospital business in a timely manner, or at all, may adversely affect its business, financial condition, results of operations and cash flows.
  • Failure or malfunction of the Hospital medical or other equipment, could adversely affect its ability to conduct the Hospital operations. Its may also experience ambulance related risks.
  • The Hospital operations could be impaired by failure of its in-house information technology systems or thirdparty technology service providers.
  • The Hospital could be exposed to risks relating to the handling of personal information, including medical data.
  • If the Hospital is unable to establish and maintain an effective internal controls and compliance system, its business and reputation could be adversely affected.
  • The Hospital has in the past been non-compliant with certain provisions of the Hospital Act, 2013, in relation to allotment of equity shares. While it has filed application for the compounding of these offences with relevant of authorities, its cannot assure you that the compounding application will be resolved in the Hospital favour or its will not be penalised for any of the contraventions.
  • The Hospital has high fixed costs, which can adversely impact its profitability. Further, if the Hospital fail to achieve favorable pricing on medical consumables, pharmacy items, drugs, and surgical instruments from its suppliers or are unable to pass on any cost increases to hospital payers, its profitability could be materially and adversely affected.
  • The Hospital has incurred net loss in the past, and its may not be able to achieve or maintain profitability in the future.
  • The Hospital developing or to be developed units, specialties, and facilities may experience delays in obtaining the required approvals, in reaching full operational capacity and may not achieve the synergies and other benefits its expect from such facilities.
  • The Hospital has outstanding litigation against its an adverse outcome of which may adversely affect the Hospital business, reputation, financial condition, and results of operations.
  • The Proforma Financial Information included in this Draft Red Herring Prospectus is not indicative of its future financial condition or results of operations.
  • The Hospital relies on financing from banks or financial institutions to carry on its business operations, and inability to obtain additional financing on terms favourable to the Hospital or at all could have an adverse impact on its financial condition. If the Hospital is unable to raise additional capital, its business and future financial performance could be adversely affected. A downgrade in credit rating could also adversely impact interest costs or access to future borrowings. The Hospital inability to meet its obligations, including financial and other covenants under the Hospital debt financing arrangements could adversely affect its business, results of operations and cash flows.
  • The Hospital enter into contracts with third-party service providers, third party administrators and insurers that could be terminated. The Hospital is also empaneled with several government organisations including Employees' State Insurance Corporation ("ESIC"), Central Government Health Scheme ("CGHS"), Ex-Servicemen Contributory Health Scheme ("ECHS"), as well as public sector undertakings and private enterprises. Any breach or termination or non-renewal of such contracts could have a material adverse impact on its business, reputation, financial condition, results of operations and prospects.
  • Delays in receiving payment of outstanding dues from third parties may affect the Hospital business, financial condition, cash flows and results of operations.
  • The Hospital intend to invest in the Company and Subsidiaries (AKS and Ramraja), to fund capital expenditure and repayment of borrowing in part or full. Its placed purchase order for certain medical equipment of AKS and Ramraja and have not entered into any definitive arrangements for remaining medical equipment and availed quotation from vendors to utilize certain portions of the Net Proceeds of the Offer. The Hospital proposed schedule of implementation and deployment of Net Proceeds may also be subject to delays and its may have to reduce or extend the deployment period for the stated objects.
  • The Hospital may not be able to grow its business due to a failure in successfully implementing all the Hospital growth strategies.
  • The Hospital registered office and three out of four of its hospitals are located on leased premises. Any termination, inability to renew or inability to terminate the Hospital lease agreements, or breach of its lease agreements by the counterparty, for the Hospital offices or its may lead to disruptions in the Hospital operations and affect its business operations.
  • The Hospital inability to protect or use its intellectual property rights or comply with intellectual property rights of others may have a material adverse effect on its business and reputation.
  • The Hospital insurance coverage may not adequately protect it and this may have an adverse effect on its business and revenues.
  • The Hospitals are susceptible to risks arising on account of fire, natural disasters or other incidents.
  • The Hospital is dependent on a number of key personnel, including its Promoters and senior management, and the loss of or the Hospital inability to attract or retain such persons could adversely affect its business, financial condition, results of operations and cash flows.
  • The Hospital may be subject to labour unrest, slowdowns and work stoppages, which could affect its reputation, business, financial condition and results of operations.
  • The average cost of acquisition of Equity Shares held by the Hospital Promoters and the Selling Shareholders may be less than the Offer Price.
  • In the event that the Hospital Net Proceeds to be utilised towards inorganic growth initiatives are insufficient for the cost of its proposed inorganic acquisition, the Hospital may have to seek alternative forms of funding.
  • Certain of the Hospital Subsidiaries has negative net worth which may adversely impact its financial condition and results of operations.
  • Various challenges currently faced by the healthcare industry in India may adversely affect the Hospital business, results of operations and financial condition.
  • The Hospital is exposed to the risks associated to foreign exchange fluctuations, which could adversely affect its financial condition, results of operations and cash flows.
  • The Hospital funding requirements and the proposed deployment of Net Proceeds are not appraised by any bank financial institution, or independent agency, which may affect its business and results of operations. Any variation in the utilisation of the Net Proceeds as disclosed in this Draft Red Herring Prospectus shall be subject to certain compliance requirements, including prior Shareholders' approval.
  • The Hospital has certain contingent liabilities that may adversely affect its business, results of operations, financial condition and prospects.
  • The Hospital has in the past entered into related party transactions and may continue to do so in the future, which may potentially involve conflicts of interest with the equity shareholders.
  • Certain of the Hospitals Directors and Key Managerial Personnel hold Equity Shares in the Company and are therefore interested in its performance in addition to their remuneration and reimbursement of expenses.
  • The Hospital has in this Draft Red Herring Prospectus included certain Non-GAAP Measures and certain other industry measures related to its operations and financial performance. These Non-GAAP Measures and industry measures may vary from any standard methodology that is applicable across the Indian healthcare industry, and therefore may not be comparable with financial or industry related statistical information of similar nomenclature computed and presented by other companies.
  • Industry information included in this Draft Red Herring Prospectus has been derived from an industry report commissioned by it, and paid for by the Hospital for such a purpose.
  • Conflicts of interest may arise out of common business objects between the Company and its Subsidiaries.
  • The emergence and effects related to a pandemic, epidemic or outbreak of an infectious disease could adversely affect the Hospital operations.
  • The Hospital has not been able to trace certain corporate records of its Subsidiary, Ramraja Multispeciality Hospital & Trauma Centre Private Limited.
  • The requirements of being a publicly listed company may strain its resources.
  • The Hospital quarterly results may fluctuate for a variety of reasons and may not fully reflect the underlying performance of its business.
  • The Company will not receive the entire proceeds from the Offer. Some of its Shareholders are selling shares in the Offer and will receive proceeds as part of the Offer for Sale.
  • The Company has availed and may continue to avail in the future certain unsecured loans which may be recalled by its lenders at any time.
  • Its Promoters, Ajay Kumar Tyagi and Kapil Kumar, have provided personal guarantees in relation to certain loan facilities availed by it, which if revoked may require alternative guarantees, repayment of amounts due or termination of the facilities and may adversely impact its cash flow, business and result of operations.
  • Its promoters and members of its Promoter Group will continue to retain control over the Company after completion of the Offer, which will allow them to influence the outcome of matters submitted for approval of its shareholders.
  • Continue to improve its quality of care and operational efficiencies.
  • Introduce new specialties at existing hospitals.
  • Augment scale through organic and inorganic manner in current markets and expand into adjacent regions.
  • Continue to attract, engage and train prominent, skilled doctors and other healthcare professionals.
  • Further leverage technology to grow its operations.
  • Grow its medical tourism segment to attract more international patients.

Yatharth Hospital & Trauma Care Services Ltd IPO Promoter Holding

Pre Issue Share Holding 56.37%
Post Issue Share Holding 0%

Yatharth Hospital & Trauma Care Services Ltd IPO Subscription Status (Bidding Detail)

The Yatharth Hospital & Trauma Care Services Ltd IPO is subscribed 36.16 times on Jul 28, 2023 05:00:00 PM. The public issue subscribed 8.34 times in the retail category, 85.1 times in the QIB category, and 37.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category QIB NII Retail Employee Total
Subscription (times) 85.1 37.22 8.34 - 36.16

Yatharth Hospital & Trauma Care Services Ltd IPO Prospectus

Yatharth Hospital & Trauma Care Services Ltd IPO Listing Date

Listing Date 07 Aug 23
BSE Script 543950
NSE Symbol YATHARTH
Listing In BSE, NSE
ISIN INE0JO301016
IPO Price ₹300
Face Value ₹10

Yatharth Hospital & Trauma Care Services Ltd IPO Registrar

Link Intime India Pvt Ltd

Phone: +91 22 4918 6200
Email: yatharth.ipo@linkintime.co.in
Website: www.linkintime.co.in

Yatharth Hospital & Trauma Care Services Ltd IPO Lead Manager(s)

  1. Intensive Fiscal Services Pvt Ltd
  2. Ambit Pvt Ltd
  3. IIFL Securities Ltd

FAQs on Yatharth Hospital & Trauma Care Services Ltd IPO

Yatharth Hospital & Trauma Care Services Ltd IPO, which opens for subscription from 26-Jul-2023 to 28-Jul-2023 has an issue size of ₹686.55 crore. The issue type is book building issue.

In case of pre-apply, your IPO order will be placed on the Exchange as soon as the official bidding for Yatharth Hospital & Trauma Care Services Ltd IPO begins. You will receive a UPI request within 24 hours after the bidding period opens.

Yatharth Hospital & Trauma Care Services Ltd IPO Opens for subscription from 26-Jul-2023 to 28-Jul-2023.

The lot size of Yatharth Hospital & Trauma Care Services Ltd is 50 shares. Retail investors can subscribe to minimum 1 lot and maximum 13 lots. The minimum and maximum application value is ₹15000 and ₹195000 respectively.

Allotment date for Yatharth Hospital & Trauma Care Services Ltd is 02-Aug-2023 and refund of application amount (in case allotment is not received) will begin from 03-Aug-2023. If your allotment goes through, then shares will be credited in your Demat account by 04-Aug-2023.

The registrar for Yatharth Hospital & Trauma Care Services Ltd IPO is Link Intime India Pvt Ltd. You can check your IPO allotment status on the registrar's website.

The shares of Yatharth Hospital & Trauma Care Services Ltd are proposed to be listed on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Power your investments with our smart trading platforms

mobilefooterimg
  • app_download_icon_img
    5 million+
    App downloads
  • 1_Click_icon_img
    1-Click
    Order Placement
  • higherreturns_icon_img
    2,361 Crore+
    Average Daily Turnover
Download App